Jehovah's Witnesses

被引:0
作者
Brydon, Catherine [1 ,2 ]
机构
[1] Western Infirm & Associated Hosp, Glasgow, Lanark, Scotland
[2] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
关键词
Blood products; blood transfusion; erythropoietin; informed consent; intraoperative cell salvage; Jehovah's Witnesses; refusal;
D O I
10.1016/j.mpaic.2012.11.015
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The Jehovah's Witness society is a Christian movement established 140 years ago. It has around 7 million members worldwide who believe that the Bible prohibits the transfusion of blood and its primary components. Some minor components of plasma and clotting factors may be acceptable to some members of the faith. Similarly some will accept intra-operative cell salvage where their own blood from the surgical site can be aspirated and returned to them provided the blood remains within a closed circuit and is never stored. A competent adult may refuse or accept any treatment without giving a reason. These wishes must be respected and followed even if the patient's life is at risk. Senior medical staff must be involved in the care of Jehovah's Witnesses from the outset. They must employ any techniques which will optimize the patient's haemoglobin and minimize blood loss. This ranges from iron and erythropoietin pre- and postoperatively to careful patient positioning and choice of anaesthetic technique to meticulous haemostasis by surgeons. Alternatives to red blood cells remain elusive despite years of research. When faced with life-threatening haemorrhage these patients are likely to require intensive care to ensure adequate oxygenation, possibly for a prolonged period.
引用
收藏
页码:79 / 81
页数:3
相关论文
共 7 条
[1]   A REVIEW OF BLOOD SUBSTITUTES: EXAMINING THE HISTORY, CLINICAL TRIAL RESULTS, AND ETHICS OF HEMOGLOBIN-BASED OXYGEN CARRIERS [J].
Chen, Jiin-Yu ;
Scerbo, Michelle ;
Kramer, George .
CLINICS, 2009, 64 (08) :803-813
[2]  
GMC Publication, 2008, CONS PAT DOCT MAK DE
[3]   Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle†‡ [J].
Kotze, A. ;
Carter, L. A. ;
Scally, A. J. .
BRITISH JOURNAL OF ANAESTHESIA, 2012, 108 (06) :943-952
[4]   Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications [J].
Madjdpour, C ;
Spahn, DR .
BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (01) :33-42
[5]  
Royal College of Surgeons of England, COD PRACT SURG UNPUB
[6]  
The Association of Anaesthetists of Great Britain and Ireland, 2005, MAN AN JEH WITN MAN AN JEH WITN, V2nd
[7]  
UK Blood Transfusion Services, 2012, HDB TRANSFUSION MED